I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...
As millions of Americans attempt to quit nicotine and move away from sugar-loaded energy drinks, a veteran-founded startup is betting that performance doesn't have to come with dependency.
Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...
This motivational speech inspires you to embrace a mindset of constant improvement and transformation, fostering a relentless drive for growth, learning, and evolving to become stronger and ...
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.
EASTPARK The road to recovery features numerous avenues, as the afternoon keynote speaker of the eighth annual Bridges Out of Addiction symposium summarized. “There’s not one pathway to recovery,” ...
Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...
Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...
A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction ...
Lev Facher covers the U.S. addiction and overdose crisis. The White House on Thursday unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic, pledging to align ...
Researchers at Washington University School of Medicine in St. Louis found that drugs known as GLP‑1 receptor agonists appear to reduce the risk of substance-use disorders and serious harms linked to ...